|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2002-10-16
|
|
pubmed:abstractText |
To compare the relative cost effectiveness of salmeterol (50 microg)/ fluticasone propionate (100 microg) with that of oral montelukast (10mg) as initial maintenance therapy in patients with persistent asthma uncontrolled on short-acting beta2-agonist therapy alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1170-7690
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
909-18
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12381242-Acetates,
pubmed-meshheading:12381242-Adolescent,
pubmed-meshheading:12381242-Adult,
pubmed-meshheading:12381242-Aged,
pubmed-meshheading:12381242-Albuterol,
pubmed-meshheading:12381242-Androstadienes,
pubmed-meshheading:12381242-Anti-Asthmatic Agents,
pubmed-meshheading:12381242-Asthma,
pubmed-meshheading:12381242-Chronic Disease,
pubmed-meshheading:12381242-Cost-Benefit Analysis,
pubmed-meshheading:12381242-Double-Blind Method,
pubmed-meshheading:12381242-Drug Combinations,
pubmed-meshheading:12381242-Female,
pubmed-meshheading:12381242-Humans,
pubmed-meshheading:12381242-Male,
pubmed-meshheading:12381242-Middle Aged,
pubmed-meshheading:12381242-Quinolines
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
|
|
pubmed:affiliation |
Allergy/Asthma Section, Arnett Clinic, Lafayette, Indiana 47904, USA. Sheth@arnett.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
